Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction
- PMID: 18290855
- DOI: 10.1111/j.1464-5491.2007.02338.x
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction
Abstract
Aims: Erectile dysfunction (ED) is a common comorbidity in men with diabetes mellitus. Tadalafil 10 or 20 mg taken on demand is efficacious and safe for men with diabetes and ED. Recently, continuous treatment with tadalafil has been proposed, addressing ED management as any other chronic condition. This study examined whether once-daily tadalafil 2.5 and 5 mg is efficacious for men with diabetes and ED.
Methods: This randomized, double-blind, placebo-controlled, multicentre, 12-week study enrolled 298 men with diabetes and ED to once-daily treatment with placebo, tadalafil 2.5 mg or tadalafil 5 mg. Primary efficacy measures were International Index of Erectile Function Erectile Function (IIEF EF) Domain score, and patient success rates for vaginal penetration and completion of intercourse. Patient satisfaction, endothelial function biomarkers, and safety were also assessed.
Results: Patients receiving either dose of tadalafil had clinically and statistically significant improvements in IIEF EF and statistically significant improvements in mean success rates for vaginal penetration, completion of intercourse, and overall treatment satisfaction (P < or = 0.005 tadalafil vs. placebo, all measures). Endothelial dysfunction biomarkers were unchanged. The most common adverse events were headache, back pain and dyspepsia.
Conclusions: In this first study of men with diabetes and ED, once-daily tadalafil 2.5 and 5 mg was efficacious and well tolerated, suggesting this may be an alternative to on-demand treatment for some men, eliminating the need to plan sex within a limited timeframe.
Similar articles
-
Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.BJU Int. 2004 Oct;94(6):871-7. doi: 10.1111/j.1464-410X.2004.05049.x. BJU Int. 2004. PMID: 15476525 Clinical Trial.
-
Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.Eur Urol. 2004 Sep;46(3):362-9; discussion 369. doi: 10.1016/j.eururo.2004.04.026. Eur Urol. 2004. PMID: 15306109 Clinical Trial.
-
Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.Eur Urol. 2006 Aug;50(2):351-9. doi: 10.1016/j.eururo.2006.02.052. Epub 2006 Mar 20. Eur Urol. 2006. PMID: 16766116 Clinical Trial.
-
Erectile function and assessments of erection hardness correlate positively with measures of emotional well-being, sexual satisfaction, and treatment satisfaction in men with erectile dysfunction treated with sildenafil citrate (Viagra).Urology. 2006 Sep;68(3 Suppl):26-37. doi: 10.1016/j.urology.2006.06.027. Urology. 2006. PMID: 17011373 Review.
-
Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.Urology. 2006 Sep;68(3 Suppl):17-25. doi: 10.1016/j.urology.2006.05.041. Urology. 2006. PMID: 17011372 Review.
Cited by
-
Treatment Outcomes of Diabetic Patients With Erectile Dysfunction Prescribed High-Dose Tadalafil.Cureus. 2023 Feb 9;15(2):e34812. doi: 10.7759/cureus.34812. eCollection 2023 Feb. Cureus. 2023. PMID: 36915849 Free PMC article.
-
Bibliometric and visualization analysis of literature relating to diabetic erectile dysfunction.Front Endocrinol (Lausanne). 2022 Dec 9;13:1091999. doi: 10.3389/fendo.2022.1091999. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36568113 Free PMC article.
-
Effect of low-dose tadalafil once daily on glycemic control in patients with type 2 diabetes and erectile dysfunction: a randomized, double-blind, placebo-controlled pilot study.Diabetol Metab Syndr. 2022 Apr 21;14(1):56. doi: 10.1186/s13098-022-00825-w. Diabetol Metab Syndr. 2022. PMID: 35449082 Free PMC article.
-
Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.Diabetes Metab Res Rev. 2022 Feb;38(2):e3494. doi: 10.1002/dmrr.3494. Epub 2021 Sep 21. Diabetes Metab Res Rev. 2022. PMID: 34514697 Free PMC article. Review.
-
Role of application of tadalafil 5 mg once-daily (≥6 months) in men with erectile dysfunction from six randomized controlled trials.Transl Androl Urol. 2020 Jun;9(3):1405-1414. doi: 10.21037/tau-19-809. Transl Androl Urol. 2020. PMID: 32676425 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical